Number of beds, n | ||||||||
---|---|---|---|---|---|---|---|---|
20–49 beds | 50–99 beds | 100–299 beds | 300–499 beds | ≥ 500 beds | Total | p-value* | ||
n = 196 | n = 588 | n = 1569 | n = 717 | n = 344 | n = 3414 | |||
(1) Average out-of-hospital prescription issuance rate (%) | 64.4 | 65.0 | 67.6 | 76.1 | 79.7 | 70.4 | - | |
(2) Cooperation tool (except community cooperation systems using ICT) for sharing patient information with other healthcare delivery facilities | ||||||||
(2-A) Information shared with community pharmacies, other hospitals, or long-term nursing homes, n (%) | 64 (32.7) | 247 (42.0) | 719 (45.8) | 439 (61.2) | 221 (64.2) | 1690 (49.5) | < 0.0001 | |
(2-B) Information shared with community pharmacies (corresponding to 2-B-1 to 2-B-3), n (%) | 38 (19.4) | 168 (28.6) | 580 (37.0) | 393 (54.8) | 208 (60.5) | 1387 (40.6) | < 0.0001 | |
If “Yes” to the above, the method of sharing information is: | ||||||||
(2-B-1) Drug summary, n (%) | 24 (63.2) | 103 (61.3) | 333 (57.4) | 168 (42.7) | 73 (35.0) | 701 (50.5) | < 0.0001 | |
(2-B-2) Tracing report, n (%) | 10 (26.3) | 52 (31.0) | 273 (47.1) | 260 (66.2) | 158 (76.0) | 753 (54.3) | < 0.0001 | |
(2-B-3) Other, n (%) | 6 (15.8) | 29 (17.3) | 67 (11.6) | 36 (9.2) | 32 (15.4) | 170 (12.3) | 0.39 | |
(2-C) Information shared with other hospitals (corresponding to 2-C-1 to 2-C-3), n (%) | 54 (27.6) | 211 (35.9) | 555 (35.4) | 293 (40.9) | 128 (37.2) | 1241 (36.4) | 0.007 | |
If “Yes” to the above, the method of sharing information is: | ||||||||
(2-C-1) Drug summary, n (%) | 43 (79.6) | 164 (77.7) | 435 (78.4) | 223 (76.1) | 95 (74.2) | 960 (77.4) | 0.30 | |
(2-C-2) Tracing report, n (%) | 4 (7.4) | 18 (8.5) | 74 (13.3) | 46 (15.7) | 26 (20.3) | 168 (13.5) | 0.0005 | |
(2-C-3) Other, n (%) | 10 (18.5) | 42 (19.9) | 92 (16.6) | 54 (18.4) | 22 (17.2) | 220 (17.7) | 0.72 | |
(D) Information shared with long-term nursing homes (corresponding to 2-D-1 to 2-D-3), n (%) | 36 (18.4) | 162 (27.6) | 427 (27.2) | 219 (30.5) | 89 (25.9) | 933 (27.3) | 0.07 | |
If “Yes” to the above, the method of sharing information is: | ||||||||
(2-D-1) Drug summary, n (%) | 30 (83.3) | 124 (76.5) | 335 (78.5) | 170 (77.6) | 69 (77.5) | 728 (78.0) | 0.79 | |
(2-D-2) Tracing report, n (%) | 2 (5.6) | 13 (8.0) | 52 (12.2) | 25 (11.4) | 11 (12.4) | 103 (11.0) | 0.19 | |
(2-D-3) Other, n (%) | 5 (13.9) | 34 (21.0) | 66 (15.5) | 35 (16.0) | 14 (15.7) | 154 (16.5) | 0.47 | |
(3) Does your facility share information via a community cooperation system using ICT? | ||||||||
Yes, n (%) | 13 (6.6) | 28 (4.8) | 165 (10.5) | 116 (16.2) | 90 (26.2) | 412 (12.1) | < 0.0001 | |
(3-A) If “Yes” to the above, do you check patient information at other healthcare delivery facilities? | ||||||||
Yes, n (%) | 7 (53.8) | 17 (60.7) | 76 (46.1) | 32 (27.6) | 26 (28.9) | 158 (38.3) | < 0.0001 | |
(3-B) If “Yes” to the above, place a checkmark next to each relevant information item. | ||||||||
(3-B-1) Disease name related to consultation/hospitalization, n (%) | 6 (85.7) | 17 (100.0) | 59 (77.6) | 24 (75.0) | 18 (69.2) | 124 (78.5) | 0.04 | |
(3-B-2) Test parameters related to consultation/hospitalization, n (%) | 3 (42.9) | 9 (52.9) | 58 (76.3) | 18 (56.3) | 16 (61.5) | 104 (65.8) | 0.96 | |
(3-B-3) Information on allergies that develop, n (%) | 3 (42.9) | 15 (88.2) | 47 (61.8) | 21 (65.6) | 14 (53.8) | 100 (63.3) | 0.37 | |
(3-B-4) Information on side effects that develop, n (%) | 2 (28.6) | 13 (76.5) | 39 (51.3) | 15 (46.9) | 14 (53.8) | 83 (52.5) | 0.18 | |
(3-B-5) Information related to adherence, n (%) | 1 (14.3) | 10 (58.8) | 19 (25.0) | 10 (31.3) | 10 (38.5) | 50 (31.6) | 0.84 | |
(3-B-6) Information related to medicines brought, n (%) | 6 (85.7) | 17 (100.0) | 59 (77.6) | 20 (62.5) | 16 (61.5) | 119 (75.3) | 0.003 | |
(3-B-7) Information related to discontinued medicines, n (%) | 1 (14.3) | 12 (70.6) | 38 (50.0) | 16 (50.0) | 12 (46.2) | 79 (50.0) | 0.94 | |
(3-B-8) Information related to medication support (formulation ingenuity), n (%) | 2 (28.6) | 9 (52.9) | 24 (31.6) | 13 (40.6) | 9 (34.6) | 57 (36.1) | 0.86 | |
(3-B-9) Information/guidance related to outpatient-prescribed pharmacotherapy, n (%) | 3 (42.9) | 7 (41.2) | 30 (39.5) | 13 (40.6) | 10 (38.5) | 63 (39.9) | 0.86 | |
(3-B-10) Information/guidance on main drugs used during the hospitalization period, n (%) | 5 (71.4) | 11 (64.7) | 45 (59.2) | 18 (56.3) | 14 (53.8) | 93 (58.9) | 0.32 | |
(3-B-11) Information/guidance on drugs used within 1 week prior to discharge, n (%) | 3 (42.9) | 9 (52.9) | 30 (39.5) | 8 (25.0) | 9 (34.6) | 59 (37.3) | 0.15 | |
(3-B-12) Guidance provided at discharge, n (%) | 0 (0.0) | 3 (17.6) | 19 (25.0) | 6 (18.8) | 5 (19.2) | 33 (20.9) | 0.71 | |
(3-B-13) Other, n (%) | 0 (0.0) | 0 (0.0) | 2 (2.6) | 1 (3.1) | 4 (15.4) | 7 (4.4) | 0.01 | |
(4) Have you introduced a system compatible with the electronic medicine notebook? | ||||||||
Yes, n (%) | 3 (1.5) | 15 (2.6) | 51 (3.3) | 29 (4.0) | 27 (7.8) | 125 (3.7) | < 0.0001 |